TATTON: Updated results for patients with EGFR-mutant NSCLC
TATTON: Updated results for patients with EGFR-mutant NSCLC
Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours
HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma
Umbralisib shows early promise for patients with marginal zone lymphoma
KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer
Gilteritinib improved survival for patients with acute myeloid leukaemia
New developments in soft tissue and bone sarcoma research
Latest updates in melanoma research
Gynaecological cancer: Where are we now?
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice
CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer
CheckMate 214: Nivolumab, ipilimumab or sunitinib in patients with advanced renal cell carcinoma